These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 7850674)
41. Care of acute myocardial infarction in Oklahoma: an update from the Cooperative Cardiovascular Project. Bratzler DW; Oehlert WH; Walkingstick K; Murray CK; Shook C; J Okla State Med Assoc; 2001 Oct; 94(10):443-50. PubMed ID: 11641999 [TBL] [Abstract][Full Text] [Related]
42. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Dawood N; Vaccarino V; Reid KJ; Spertus JA; Hamid N; Parashar S; Arch Intern Med; 2008 Oct; 168(18):1961-7. PubMed ID: 18852396 [TBL] [Abstract][Full Text] [Related]
46. Secondary prevention after myocardial infarction: facts and fallacies. Taylor SH J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S914-21. PubMed ID: 6084149 [TBL] [Abstract][Full Text] [Related]
47. [Prevention of recurrent myocardial infarct]. Kallio V Duodecim; 1981; 97(5):227-30. PubMed ID: 6113128 [No Abstract] [Full Text] [Related]
48. [Beta-blockers and secondary prevention after myocardial infarction]. Kher A; Jaillon P Therapie; 1984; 39(2):189-96. PubMed ID: 6145232 [No Abstract] [Full Text] [Related]
49. Influence of socioeconomic status on lifestyle behavior modifications among survivors of acute myocardial infarction. Chan RH; Gordon NF; Chong A; Alter DA; Am J Cardiol; 2008 Dec; 102(12):1583-8. PubMed ID: 19064009 [TBL] [Abstract][Full Text] [Related]
50. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period]. Jankowski P; Kawecka-Jaszcz K; Pajak A Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737 [TBL] [Abstract][Full Text] [Related]
51. Early intervention and prevention of myocardial infarction. Pais PS J Hypertens Suppl; 2006 Apr; 24(2):S25-30. PubMed ID: 16601557 [TBL] [Abstract][Full Text] [Related]
52. [Secondary prevention following myocardial infarction--results of long-term studies]. Berndt H Z Arztl Fortbild (Jena); 1983; 77(2):52-8. PubMed ID: 6132502 [No Abstract] [Full Text] [Related]
53. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest? Wachtel TM; Kucia AM; Greenhill JA Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517 [TBL] [Abstract][Full Text] [Related]
54. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?]. Reikvam A; Madsen S; Landmark K Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258 [TBL] [Abstract][Full Text] [Related]
55. Beta-blockers in the prevention of myocardial infarction. Hampton JR Practitioner; 1984 Jan; 228(1387):55-63. PubMed ID: 6141556 [No Abstract] [Full Text] [Related]
56. [Treatment of smoking in myocardial infarction survivors]. Menotti A; Scanga M Cardiologia; 1993 Dec; 38(12 Suppl 1):339-44. PubMed ID: 8020034 [TBL] [Abstract][Full Text] [Related]
57. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs]. Noll G; Kaufmann U; Wenzel RR; Lüscher TF Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687 [TBL] [Abstract][Full Text] [Related]